Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Advaxis Inc (ADXS)  
$0.06 0.00 (0.00%) as of 4:30 Fri 6/3


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 66,230,000
Market Cap: 4.11(M)
Last Volume: 362,100 Avg Vol: 361,089
52 Week Range: $0.062 - $0.062
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,317,716 1,317,716
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 465
  Page 9 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   O'connor Daniel Chief Executive Officer   •       –      –    2016-01-29 4 S $6.88 $60,668 D/D (8,818) 313,394     -
   O'connor Daniel Chief Executive Officer   •       –      –    2016-01-29 4 D $6.82 $4,692 D/D (688) 322,212     -
   O'connor Daniel Chief Executive Officer   •       –      –    2016-01-29 4 A $6.82 $8,866 D/D 1,300 322,900     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-01-29 4 S $6.88 $21,321 D/D (3,099) 130,557     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-01-29 4 D $6.82 $1,023 D/D (150) 133,656     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-01-29 4 A $6.82 $2,196 D/D 322 133,806     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-01-29 4 D $6.82 $539 D/D (79) 95,017     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-01-29 4 A $6.82 $1,937 D/D 284 95,096     -
   Mauro David J Chief Medical Officer   •       –      –    2015-12-31 4 D $10.06 $412 D/D (41) 166,271     -
   Mauro David J Chief Medical Officer   •       –      –    2015-12-31 4 A $10.06 $1,962 D/D 195 166,312     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2015-12-31 4 D $10.06 $734 D/D (73) 120,309     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2015-12-31 4 A $10.06 $2,938 D/D 292 120,382     -
   Bonstein Sara Chief Financial Officer   •       –      –    2015-12-31 4 D $10.06 $594 D/D (59) 94,812     -
   Bonstein Sara Chief Financial Officer   •       –      –    2015-12-31 4 A $10.06 $2,465 D/D 245 94,871     -
   O'connor Daniel Chief Executive Officer   •       –      –    2015-12-31 4 D $10.06 $2,978 D/D (296) 332,953     -
   O'connor Daniel Chief Executive Officer   •       –      –    2015-12-31 4 A $10.06 $10,674 D/D 1,061 333,249     -
   Petit Robert Chief Scientific Officer   •       –      –    2015-12-31 4 D $10.06 $473 D/D (47) 133,484     -
   Petit Robert Chief Scientific Officer   •       –      –    2015-12-31 4 A $10.06 $2,938 D/D 292 133,531     -
   Berman Richard J Director   –       •      –    2015-12-17 4 S $12.39 $177,573 D/D (14,332) 84,430     -
   Petit Robert Chief Scientific Officer   •       –      –    2015-11-30 4 D $12.07 $266 D/D (22) 133,240     -
   Petit Robert Chief Scientific Officer   •       –      –    2015-11-30 4 A $12.07 $1,967 D/D 163 133,262     -
   Bonstein Sara Chief Financial Officer   •       –      –    2015-11-30 4 D $12.07 $266 D/D (22) 94,631     -
   Bonstein Sara Chief Financial Officer   •       –      –    2015-11-30 4 A $12.07 $1,642 D/D 136 94,653     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2015-11-30 4 D $12.07 $398 D/D (33) 120,091     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2015-11-30 4 A $12.07 $1,967 D/D 163 120,124     -
  465 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us